D'Oria Mario, Mendes Bernardo C, Bews Katherine, Hanson Kristine, Johnstone Jill, Shuja Fahad, Kalra Manju, Bower Thomas, Oderich Gustavo S, DeMartino Randall R
Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.
Surgical Outcomes Program, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
Ann Vasc Surg. 2020 Jan;62:35-44. doi: 10.1016/j.avsg.2019.04.009. Epub 2019 Jun 13.
Iliac branch devices (IBDs) can treat iliac and aortoiliac aneurysms (AIAs) less invasively than open surgery (OS) and preserve pelvic perfusion. Our hypothesis was that the rates of perioperative complications after treatment for AIAs are similar between IBDs and hypogastric occlusion with coil and cover (C&C), and lower than OS.
We identified patients undergoing elective AIA repair by IBD, C&C, and OS (all with infrarenal clamps) within the National Surgical Quality Improvement Program (NSQIP) vascular aneurysm specific Participant User Files (2012-2016). Baseline characteristics, procedural variables, and 30-day outcomes were compared. The primary outcomes were any major complication or death. Secondary outcomes included minor complications, total operative time, total and intensive care unit length of stay (LOS), and reinterventions. Multivariable logistic regression assessed differences in major complications between IBD and C&C/OS after adjusting for patient and procedural variables.
We identified 593 patients (83% men, mean age 71.6 ± 9 years) undergoing elective AIA repair (IBD = 283, C&C = 118, and OS = 192). Patient age and American Society of Anesthesiology (ASA) classification varied significantly between groups. Mean aneurysm diameter was higher for OS and similar between IBD and C&C (5.9 cm vs. 5.5 cm and 5.2 cm, respectively, P < 0.001). OS was associated with higher rate of major complications (65.5% vs. IBD: 8.8% and C&C: 13.6%, P=<0.001) and higher mortality (3.6% vs. IBD: 0.7% and C&C: 0%, P = 0.017). Minor complications and reinterventions were similar. IBD patients had significantly shorter total operative time and total and intensive care unit LOS. After adjustment, OS was associated with higher major complications compared with IBD (Odds ratio [OR]: 11.3, 95% confidence interval [CI]: 5.8-21.9, P < 0.001), primarily because of the use of transfusions (major complications excluding transfusions OR: 1.3, 95% CI: 0.6-2.8, P = 0.52). Major complications between IBD and C&C were similar (OR: 1.6, 95% CI: 0.8-3.4, P = 0.23).
The use of IBDs for elective treatment of AIAs is associated with favorable perioperative outcomes and a lower rate of major complications compared with OS, primarily because of fewer transfusions. IBDs use has perioperative outcomes similar to C&C with the associated benefit of preserving pelvic perfusion. Pending long-term durability results for this technique, IBDs appear to be associated with several perioperative advantages in patients with AIAs compared with OS and C&C.
与开放手术(OS)相比,髂支装置(IBD)治疗髂动脉瘤和主髂动脉瘤(AIA)的侵入性更小,并能保留盆腔灌注。我们的假设是,IBD和带线圈及覆膜的髂内动脉闭塞术(C&C)治疗AIA后的围手术期并发症发生率相似,且低于OS。
我们在国家外科质量改进计划(NSQIP)血管动脉瘤特定参与者用户文件(2012 - 2016年)中确定了接受IBD、C&C和OS(均使用肾下夹)进行择期AIA修复的患者。比较了基线特征、手术变量和30天的结果。主要结局是任何重大并发症或死亡。次要结局包括轻微并发症、总手术时间、总住院时间和重症监护病房住院时间(LOS)以及再次干预。多变量逻辑回归在调整患者和手术变量后评估IBD与C&C/OS之间重大并发症的差异。
我们确定了593例接受择期AIA修复的患者(83%为男性,平均年龄71.6±9岁)(IBD组 = 283例,C&C组 = 118例,OS组 = 192例)。各组之间患者年龄和美国麻醉医师协会(ASA)分级差异显著。OS组的平均动脉瘤直径更大,IBD组和C&C组相似(分别为5.9 cm vs. 5.5 cm和5.2 cm,P < 0.001)。OS与更高的重大并发症发生率相关(65.5% vs. IBD组:8.8%,C&C组:13.6%,P = <0.001)和更高的死亡率(3.6% vs. IBD组:0.7%,C&C组:0%,P = 0.017)。轻微并发症和再次干预相似。IBD组患者的总手术时间以及总住院时间和重症监护病房住院时间明显更短。调整后,与IBD相比,OS与更高的重大并发症相关(比值比[OR]:11.3,95%置信区间[CI]:5.8 - 21.9,P < 0.001),主要是因为输血的使用(排除输血的重大并发症OR:1.3,95% CI:0.6 - 2.8,P = 0.52)。IBD和C&C之间的重大并发症相似(OR:1.6,95% CI:0.8 - 3.4,P = 0.23)。
与OS相比,使用IBD进行AIA的择期治疗与良好的围手术期结局和更低的重大并发症发生率相关,主要是因为输血较少。IBD的使用具有与C&C相似的围手术期结局,并具有保留盆腔灌注的相关益处。在该技术的长期耐久性结果出来之前,与OS和C&C相比,IBD在AIA患者中似乎具有几个围手术期优势。